Form 4 for TARA Protara Therapeutics, Inc.
Accepted 2022-07-19 00:00:00 ET · period of report 2022-07-16 · accession 0001213900-22-040288 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-19 | 2022-07-16 | TARA | Fry Hannah | VP, Ctrl | A - Grant | $0.00 | +25.0K | 27.6K | +962% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-16 | A | A | 25,000 | $0.00 | 27,600 | D | — | — | (F1) The shares being reported are being issued pursuant to a restricted stock unit (RSU) award, of which each RSU represents a contingent right to receive one share of Issuer's common stock. The RSUs vest one hundred percent (100%) on the first anniversary of July 16, 2022. |